Speech-Language Pathologists in Monroe, WI Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Muriel Kathleen Brumley, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: N3150 State Road 81, Monroe, WI 53566 Phone: 608-325-2171

Hannah Kernen Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-832-5914

Mr. Olufemi Awoyomi, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: N3150 Hwy 81, Monroe, WI 53566 Phone: 608-325-2171

Ching-hsuan Peng, MS/CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-325-9141

Celia Deckelman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: N3150 Wi-81, Monroe, WI 53566 Phone: 608-325-2171

Mrs. Jennifer A Newcomer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-325-9141

Mrs. Terry R Faith, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-329-6600    Fax: 608-329-6594

Shekina Cardona Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-325-9141

News Archive

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.

A voluntary recall program announced by CONMED Linvatec

CONMED Corporation's (NASDAQ: CNMD) CONMED Linvatec unit announced today a voluntary recall for certain model numbers of the PRO5 & PRO6 series battery handpieces manufactured prior to May 31, 2008, and certain lots of the MC5057 Universal Cable manufactured prior to December 1, 2006 used with certain of CONMED Linvatec's electric powered handpieces.

Anxious and depressed patients more likely to report worse results after hip replacement

Patients who suffer from anxiety and depression are more likely to report worse results after a hip replacement. A year-long wait for the operation also entails significant costs to both society and the individual, reveals a new thesis from the University of Gothenburg, Sweden.

Read more Medical News

› Verified 6 days ago